The new smart pill organizer has been co-developed with RxCap and solidifies Centor's position as a leader in innovative drug containment and medication adherence solutions. It is now available to U.S. pharmacies through Centor's remote monitoring service.
The winning product was the company’s SnapSlide Rx, a revolutionary child-resistant closure for prescription bottles that improves access to medications for those with physical limitations or dexterity issues.
This milestone marks the third year of a collaboration between the two organizations, reaffirming their mutual commitment to providing enhanced care and support for individuals affected by breast cancer.
The innovative solution provides real-time notifications to designated specialty pharmacy users, alerting them of data errors and missing fields.
First-of-its-kind program aims to reduce pre-requisite costs, which remain common barriers for pharmacy technicians looking to pursue a PharmD degree.
Rapidly integrates digital pharmacy business into Tractor Supply and Petsense by Tractor Supply stores.
The settlement requires Walgreens to pay at least $300 million upfront, with an additional $50 million due if the company is sold, merged, or transferred before 2032.
“These recommendations serve as a road map for health plans and pharmacists to collaborate on building sustainable models that recognize the value pharmacists bring to the health care system.”
"As chair of NACDS, I will be focused on working with industry leaders to strengthen pharmacy’s role as the front door to health care."
New customizable letter also facilitates pharmacy outreach to area OB-GYNs.
"Dupixent has the potential to improve outcomes for CSU patients who previously had limited treatment options.”
Customers will be able to shop over 37,000 SNAP-eligible items, including beverages, groceries, and snacks, on each platform, including at most CVS Pharmacy stores.
The Dowagiac clinic will be Cass Family Clinic’s third location, joining Cassopolis and Niles.
"HB1150 is bad policy that accomplishes just the opposite. It will take away access to pharmacy care in local communities, hike prescription drug spending across the state by millions of dollars each year and cost hundreds of Arkansans their jobs.”
Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1.3% to 1.6% across doses.
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
